Anxiety and Depression: Clinical Trials

2 trials for Anxiety and Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Withdrawn 1

Follow Anxiety and Depression: new trials by email Literature Review of Anxiety and Depression trials Research Report on Anxiety and Depression

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A New Intervention to Improve Function in Veterans With Anxiety and Depression
Pregnenolone, Placebo - Anxiety and Depression
Phase 2RecruitingVA Office of Research and Development842025-08-142026-10-14
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
PSIL428, Oyster mushroom - Anxiety and Depression
Phase 2WithdrawnWake Network, Inc.2022-09-152022-06-30

Narrower conditions

Anxiety Disorders (2)  ·  Depression (2)  ·  Pain (1)

Broader conditions

Behavior (2)  ·  Behavioral Symptoms (2)  ·  Mental Disorders (2)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Pregnenolone (1)  ·  pleurotolysin B, oyster mushroom (1)

Sponsors

VA Office of Research and Development (1)  ·  Wake Network, Inc. (1)

Countries

Jamaica (1)  ·  United States (1)

Top investigators

Christine E. Marx, MD MA (1)  ·  Jennifer C Naylor, PhD (1)  ·  Roger Gibson (1)  ·  Sharon White (1)

NIH funding

I01RX004287 (1)